Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid

Vaccine

Volumn 28, Issue 42, 2010, Pages 6841-6846

  Cruz, Simone C ^a   Silva, Giselle P ^a   Sampaio, Felipe J ^a   Souza, Simone L ^a   Dias, Alexandre Alves S O ^b   Milagres, Lucimar G ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Memory B cell; Neisseria meningitidis; Vaccine

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL MEMORY; KINETICS; MEMORY CELL; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SECRETORY CELL; SPLEEN; TREATMENT RESPONSE;

EID: 77956885952     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.036     Document Type: Article

References (24)

1. Stephens D.S., Greenwood B., Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007, 369:2196-2210.
2. Feavers I.M., Pizza M. Meningococcal protein antigens and vaccines. Vaccine 2009, 27S:B42-B50.
3. Sadarangani M., Pollard A.J. Serogroup B meningococcal vaccines - an unfinished story. Lancet Infect Dis 2010, 10:112-124.
4. Plested J.S., Granoff D.M. Vaccine-induced opsonophagocytic immunity to Neisseria meningitides group B. Clin Vaccine Immunol 2008, 15:799-804.
5. Wrammert J., Miller J., Akondy R. Human immunity memory to yellow fever and smallpox vaccination. J Clin Immunol 2009, 29:151-157.
6. Tangye S.G., Tarlinton D.M. Memory B cells: effectors of long-lived immune responses. Eur J Immunol 2009, 39:2065-2075.
7. Manz R.A., Thiel A., Radbruch A. A lifetime of plasma cells in the bone marrow. Nature 1997, 388:133-134.
8. Slifka M.K., Antia R., Whitmire J.K., Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998, 8:363-372.
9. Galazka A.M. The changing epidemiology of diphtheria in the vaccine era. J Infect Dis 2000, 181:S2-S9.
10. Brazil. Ministério da Saúde. Portaria n (597/GM, de 08 de abril de 2004. Institui em todo território nacional, os calendários de vacinação. Diário Oficial da União [República Federativa do Brasil], Brasília, 12 de abril de 2004. Seção 1. 69:47.
11. Fundação Nacional de Saúde-Funasa. Difteria: situação atual da doença; 2002. [accessed 23.04.2009]. http://www.funasa.gov.br/guia-epi/htm/doenc.as/difteria/index.htm.
12. Cruz S.C., Cruz A.C., Oliveira J.M., Soares A.M., Gioia C.A., Milagres L.G. Generation of long-lived plasma cells to serogroup B Neisseria meningitidis after murine immunisation with an outer membrane protein vaccine. Vaccine 2007, 25:5046-5052.
13. Sierra V.G.G., Campa C.H., García L.I., Sotolongo F.P., Izquierdo L.P., Valcarcel L.M., et al. Efficacy evaluation of the Cuban vaccine VA-MENGOC-BC® against disease caused by serogroup B Neisseria meningitidis. Neisseria 1990 1991, 129-134. Walter de Gruyter, Berlin. M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler, Thiesen B. (Eds.).
14. Nanan R., Heinrich D., Frosch M., Kreth H.W. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory-B lymphocytes. Vaccine 2002, 20:498-504.
15. Tsai C.M., Frasch C.E. Chemical analysis of major outer membrane proteins of Neisseria meningitidis: comparison of serotypes 2 and 11. J Bacteriol 1980, 141:169-176.
16. Milagres L.M., Ramos S.R., Sacchi C.T., Melles C.E.A., Vieira V.S.D., Sato H., et al. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect Immun 1994, 62:4419-4424.
17. Plikaytis B.D., Holder P.F., Carlone G.M. Program ELISA for Windows User's Manual, Version 2.01 2002, Centers for Disease Control and Prevention, Atlanta, GA, USA.
18. Holst J., Martin D., Arnold R., Huergo C.C., Oster P., O'Hallahan J., et al. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitides. Vaccine 2009, 27S:B3-B12.
19. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969, 129:1307-1326.
20. Feiring B., Fuglesang J., Oster P., Næss L., Helland O., Tilman S. Persisting immune responses indicating long-term protection after booster dose with meningococcal group b outer membrane vesicle vaccine. Clin Vaccine Immunol 2006, 13:790-796.
21. Wedege E., Høiby E.A., Rosenqvist E., Bjune G. Immune response against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 1998, 66:3223-3231.
22. Milagres L.M., Gorla M.C.A., Rebelo M.C., Barroso D.E. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunisation with an outer membrane protein vaccine. FEMS Immunol Med Microbiol 2000, 28:319-327.
23. Souvannavong V., Saidji N., Chaby R. Lipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B Lymphocytes. Infect Immun 2007, 75:4998-5003.
24. Blink E.J., Light A., Kallies A., Nutt S.L., Hodgkin P.D., Tarlinton D.M. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 2005, 201:545-554.